Mirja
Hommel
Investigadora Colaboradora
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Investigación Sanitaria de Navarra (8)
2022
-
Optimising the IgG-degrading enzyme treatment regimen for enhanced adeno-associated virus transduction in the presence of neutralising antibodies
Clinical and Translational Immunology, Vol. 11, Núm. 2
-
The role of dendritic cells in the immune niche of the peritoneum
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 1-14
2021
-
AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production
Journal of immunology (Baltimore, Md. : 1950), Vol. 206, Núm. 2, pp. 376-385
-
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11
2018
2017
-
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679
-
Adeno-associated viral vectors serotype 8 for cell-specific delivery of therapeutic genes in the central nervous system
Frontiers in Neuroanatomy, Vol. 11
2016
-
Complementary effects of interleukin-15 and alpha interferon induce immunity in hepatitis B virus transgenic mice
Journal of Virology, Vol. 90, Núm. 19, pp. 8563-8574